WALTHAM, Mass., May 26 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA), a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, announced today that it will attend the upcoming FBR Capital Markets 12th Annual Spring Investor Conference being held May 28, 2008 at the Grand Hyatt in New York. Ron Geraty, President, Health Management, and Jon Russell, Vice President, Finance, will attend. Their presentation is scheduled for Wednesday, May 28, 2008 at 9:45 a.m., and will be made available to the public through a webcast accessible through the company's website at http://www.invmed.com/investors.cfm and through FBR's website at http://www.wsw.com/webcast/fbr21/ima/ . A replay of the webcast will be available via the links above for 90 days. During their presentation Mr. Geraty or Mr. Russell may discuss and answer questions concerning business and financial developments and trends. Their responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.
An investor presentation to be provided at the conference will be made available to the public on the company's website via the link provided above.
Inverness Medical Innovations is a leading global developer of advanced
diagnostic devices and is presently exploring new opportunities for its
proprietary electrochemical and other technologies in a variety of
professional diagnostic and consumer-oriented applications including
immuno- diagnostics with a focus on women's health, cardiology an
|SOURCE Inverness Medical Innovations, Inc.|
Copyright©2008 PR Newswire.
All rights reserved